We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Bionostics | BIO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 29.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 29.75 | 29.75 |
| Top Posts |
|---|
Posted at 28/11/2012 21:30 by willydoctor Mrs Ape - I miss you!!I don't understand why so many investors get all religious with their darling stocks and if anyone is deemed guilty of not following the orthodox line then a fatwah is issued against them. FFS grow up!!! I value the contrarian opinion. I am still in SUMM - albeit with a degree of caution. They ramped the stock up to 14p on OGA news for a rights issue, then did it again at 8p - so there is a track record for shafting PIs. I am hoping that history will not repeat itself - but who knows you may be right. In the meantime - your advice and research is always welcome even if I don't agree! WD |
Posted at 04/12/2007 17:47 by aquilla This share never ceases to amaze. It is on the radar of only a few investors, ignored by the rest. In some ways not surprising, with a market cap of a mere £7m and a chart that looks horrendous. Indeed it has never caught the imagination in the way that some small caps have (remember RTD?). When I started the first BIO thread (and I originally got in back in January at 23p) there would be a couple of posts a week, if that. But what is surprising is that the share price is now languishing at 14.5p, given the fact that there are still ongoing talks which might lead to an offer of 30p and that, aside from the bid element, the fundamentals of the company offer hope for the future. With a new CEO with a turn-around track record brought in last year, the loss making divisions gone and two cash generative divisions left one would have expected the share price to have done more. Yes, there is the debt but, as has been pointed out before, hopefully the cash generative divisions will reduce this sharply. Part of the problem lies, I believe, with the illiquidity of the share. A small cap already, most of the shares are held by institutions. NMS at the moment is 1500, and 5000 traded today would have cleared the order book. A pathetic amount. I have indeed found that it can be traded in much larger quantities, without moving the share price against the trader, but how many private investors have the knowledge or persuasive powers to go down that route? Is this going to turn out to have been a good investment? Time will tell, but in the meantime we remain in the doldrums. |
Posted at 04/12/2007 14:51 by keepitup From the Group Chief Executive.Yes 20mins ago. Sounds very positive, i will print the full email: Thank you for your note. I am fully aware that you and many investors like you have had a very difficult time over the past couple of years. When I joined Ferraris Group last October, it was with the understanding that the Board of Directors would allow me to do the things necessary to revive a stagnant organization and begin to pay down the overwhelming debt. In the past thirteen months the Board has done everything possible to support my efforts with the result being a revitalization of the businesses, record trading and profits in both the third and fourth quarters of fiscal year 2007 and significant progress in paying down our debt. As you can imagine, such rapid improvement in a company's performance is recognized by knowledgeable investors as an indication that the company's true value exceeds its market capitalization. As you know, some time ago we announced to the market that Bionostics plc was in discussions with a potential acquirer. The rules of the Takeover Panel of the London Stock Exchange are such that I am unable to give you any further information until those discussions proceed to a more definitive stage, whether it be positive or negative. I believe, however, that because we were forced to make that announcement, investors who expected to hear about the outcome sooner have become unnecessarily concerned and have caused an artificial and temporary collapse of the share price. I take my responsibilities to shareholders very seriously; I believe that it is my responsibility to do what is best for our shareholders, whether it is best or preferable for me or any member of the Board or executive management. I assure you that an announcement will be made at the earliest possible moment, but until that is possible I hope that you will understand my inability to comment. Our preliminary results for fiscal year 2007 will be announced very shortly. I am confident you will then have your questions answered. If, knowing my limitations, you would like to discuss this further, please feel free to call me. I apologize for your frustration, but I believe that we will have more information in the near future. Michael H. Thomas Group Chief Executive Officer Bionostics plc |
Posted at 04/12/2007 14:41 by keepitup " record trading and profits in both the third and fourth quarters of fiscal year 2007 and significant progress in paying down our debt. As you can imagine, such rapid improvement in a company's performance is recognized by knowledgeable investors as an indication that the company's true value exceeds its market capitalization " i got an email back from the company. news looks iminent and seems like they have paid alot of debt back with extremely good 3rd and 4th quarter results. Happy to hold. |
Posted at 29/11/2007 16:27 by aquilla Just a little example of what I mean: I went back to one thread of a company (LNX) I followed for a while. This was the post:Red Dog - 25 May'07 - 13:46 - 500 of 543 "Some investment friends of mine were in Spain resently and they are of the mind that Lennox is in more trouble than published so far. They are asking. Will Lennox go under in the next 6 months?. Will the Company come cap in hand to their investors for more money to bail out the Company at 0.75p or less?. Will they make a profit in the next 3 years?, they don't think so. Should investors bite on the bullet and sell to invest elsewere?. It sounds like the time has come to take action to save what is left of ones investment." Three weeks later and he was ramping the company for all he was worth: Red Dog - 15 Jun'07 - 10:34 - 144 of 1247 Morning all. I was out all day, so I am only now catching up with today's trades. Looks positive. Not much I can add to this BB at this time. The results will consolidate the share price at 6p plus, if they state the Company is on track to return to profits and they have started to reduce their debt. At 4.5p the shares are very cheap and those not in will regret that they stood on the side lines and let this share get away. STRONG BUY I WOULD SAY. Having deramped the company so he could buy shares on the cheap, he then ramped the company for all he could so he could offload!! |
Posted at 28/11/2007 09:14 by vlain The dips for the last two days will definately scare a lot of short term investors who came in last week @11p, who will take their small profit and run.Bearing that in mind, I would expect next week to be a more accurate reflection of the true "current" value. IMHO |
Posted at 22/11/2007 11:47 by bluefishin aquilla, Dont try to put off the day dealers. The share isn't written on only "long term investors".Bearing in mind the recent difficult conditions of the market, everybody has a right to take opportunities as they come. Happy to admit that, Im using this share to recover some of last days' loses. Bluefishin. |
Posted at 22/11/2007 11:46 by william47 you reckon it was inevitable so youll have bought more aquilla.dont knock new investors or you might find yourself alone at 1p.your choice.d-ck |
Posted at 29/10/2007 16:30 by tunturiflyer NAV have 26% of the equity. Presumably they are not completely stupid. Either they are busy trying to find folk that would be prepared to buy each of the two bits of the company. Alternatively, if they took it private they would save a fair amount of LSE listing, audit, goverence and useless management expenses. So maybe they are waiting for the debt markets to sort themselves out, so they can get the debt at lower cost. They would know that they are not going to be able to offload 26% of the equity to a bunch of private investors, so they are going to have to do something. |
Posted at 30/9/2007 18:32 by aquilla Well, it looks like the news is out! In today's Sunday Times:"The activist fund management group North Atlantic Value is poised to launch a takeover bid for Bionostics valuing the medical diagnostics firm at about £15m. According to bankers, North Atlantic, which is backed by a group of investors, is planning to bid 30p a share for Bionostics. The offer is a 30% premium to the share price of 23p on Friday. North Atlantic is already Bionostic's largest shareholder with a 26.76% stake held in four of the funds it manages. Bionostics shares have slumped by 85% since hitting 170p in 2004. The group sold off its cardiac monitoring assets in June 2006 to Spacelabs Healthcare for £14m. However, in April Bionostics announced it had swung to a £490,000 loss for the first six months of the year against a profit of £536,000 a year earlier." I spoke to the company earlier in the week and got a pretty strong hint that news (one way or the other) would be coming soon. The figure also coincides with the maximum price that N.Atlantic previously paid for the shares and what I thought the offer price would be. Interesting that there was a sharp drop in share price just before the conclusion of talks (if this turns out to be the case). I mentioned in a previous post the case of RTD where exactly the same thing happened: a sharp drop, designed to trigger stop losses and make shareholders think bad news was on the way, only to be followed by the announcement of successful conclusion of talks! Ps I think the share price will rocket tomorrow. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
